Pulmonary Consequences after COVID-19

Apr 22, 2025

Dr. Melisa Chang presents a detailed analysis of the pulmonary sequelae of COVID-19. She addressed the history and epidemiology of the virus, the impact of long COVID, and the most frequent respiratory complications, such as ground-glass opacities, pulmonary fibrosis, organizing pneumonia, bronchiectasis, and pulmonary vascular disease. She explained possible mechanisms, risk factors, and the relationship with idiopathic pulmonary fibrosis. She also reviewed therapeutic options such as antivirals, pulmonary rehabilitation, antifibrotic drugs, and transplantation, highlighting the need for more studies to optimize post-COVID management.
Dr. Melisa Chang is a pulmonologist and specialist in critical care and sleep medicine at the Los Angeles Veterans Hospital, and a clinical assistant professor at UCLA. Originally from Peru, with Chinese ancestry, she has extensive research experience and has published numerous articles on lung diseases and post-infectious sequelae.
Chapters and Timestamps
1. History and Epidemiology of COVID-19 – 2:50
2. Long COVID: Definition, Symptoms, and Risk Factors – 11:56
3. Mechanisms and Theories on Long COVID – 14:00
4. Post-COVID Pulmonary Complications (Parenchyma) – 19:39
5. Post-COVID Pulmonary Fibrosis and Similarities with IPF – 25:09
6. Airway Damage and Pulmonary Vascular Disease – 33:37
7. Treatment Options: Antivirals, Steroids, Antifibrotics, and Rehabilitation – 39:20
8. Lung Transplantation in Post-COVID Sequelae – 42:24
Disclaimer
This video is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor for medical concerns.
The page was last reviewed on September 28, 2025